Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medi... (re the possibilities our technology has ...)

Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center

Date:2/20/2013

re the possibilities our technology has enabled."

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem completed dosing of the last patient in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig 's disease, in August 2012; the trial ends six months after that last surgery. Neuralstem has been awarded orphan status designation by the FDA for its ALS cell therapy.

In addition to ALS, the company is also targeting major central nervous system conditions with its NSI-566 cell therapy platform, including spinal cord injury, ischemic stroke and glioblastoma (brain cancer). The company received approval to commence a Phase I safety trial in chronic spinal cord injury in January 2013.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions. The company is in a Phase Ib safety trial evaluating NSI-189, its first neurogenic small molecule compound, for the treatment of major depressive disorder (MDD). Additional indications could include chronic traumatic encephalopathy (CTE), Alzheimer's disease, and post-traumatic stress disorder (PTSD).

For more information, please visit www.neuralstem.com or connect with us on Twitter,

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Neuralstem Updates ALS Stem Cell Trial Progress
2. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
3. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
4. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
5. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
6. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
7. Neuralstem Announces Proposed Public Offering
8. Neuralstem to Raise $7.0 Million in Registered Direct Offering
9. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
10. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
11. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds

Post Your Comments:

(Date:6/17/2013)... 17, 2013 As the Share Repurchase Resolution has been ... for Elan Corporation, plc (NYSE: ELN ) has ... of the Proceedings referred to below and any consequent decision ... be effective to the extent that it would have been ... the Share Repurchase Resolution being passed. There can be no ...

(Date:6/17/2013)... -- Southern Research Institute today announced that ... its Board of Directors to serve as president and ... (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ) ... served as president and CEO of Southern Research Institute ... year after 34 years of service at Southern Research. ...

(Date:6/17/2013)... , June 17, 2013 Royal ... new capabilities for its Iterative Model Reconstruction ... that will simultaneously bring enhanced benefits to ... announced at the International Society for Computed ... Multidetector-Row CT, and include IMR,s ability to ...

[0] Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today [0] Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO [0] Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality

... Calif., Dec. 11 Maxygen, Inc. (Nasdaq: MAXY ), ... of protein drugs, today announced that it has extended the ... repurchase 6,557,377 shares of its common stock, which was commenced ... previously scheduled to expire at 12:00 midnight, New York City ...

... , , , NATICK, Mass., Dec. ... announced the pricing of a public offering of $2 billion aggregate ... statement. The public offering consists of $850 million of 4.50 ... due January 2020 and $300 million of 7.375 percent notes due ...

Cached Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3

Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer Boston Scientific Announces Pricing of $2 Billion of Senior Notes

(Date:6/18/2013)... June 18, 2013 The Semi Truck ... of families dealing an extremely serious injury involving a innocent ... wait too long before trying to assemble a top legal ... the absolute best truck accident law firms in the nation, ... law firm, and they end up getting burned. We want ...

(Date:6/18/2013)... The Columbia Center for Theatrical Arts’ (CCTA’s) ... SHREK The Musical July 18-21 at Glenelg High School. ... started it all, SHREK is the hilarious story of everyone’s ... faraway kingdom turned upside down, things get ugly when an ... to rescue a feisty princess. Throw in a donkey who ...

(Date:6/18/2013)... Upland, CA (PRWEB) June 18, 2013 ... Women’s Choice Award®, distinguishing it as one of ... in Orthopedics. The award is based on robust ... well as clinical excellence considerations. WomenCertified awards products ... women and serves to empower women to make ...

(Date:6/18/2013)... For as long as employers, sporting officials, ... have found ways to cheat them. It’s an incessant, ... seemingly fool-proof method for detecting a certain drug, only ... around it. One need only consider high profile athletes ... a world-wide network of physicians and chemists at a ...

(Date:6/18/2013)... 2013 Today, NOVAtime Technology, Inc. ... development company, announced that Cascade Gasket and Manufacturing ... 4000 Software-as-a-Service (SaaS) solution to streamlines its ... entire workforce. , Founded in 1946, Cascade ... seal, gasket, and clamp block parts primarily for ...

Breaking Medicine News(10 mins):Health News:Semi Truck Accident Victims Center Now Warns Families of A Innocent Victims Seriously Hurt In A Semi Truck Crash To Get A Very Good Legal Team And They Offer To Help 2 Health News:Everyone’s Favorite Ogre Coming to Town! CCTA’s Teen Professional Theatre Offers Area Premier of SHREK The Musical 2 Health News:San Antonio Community Hospital Earns the Women’s Choice Award for Excellence in Orthopedics 2 Health News:San Antonio Community Hospital Earns the Women’s Choice Award for Excellence in Orthopedics 3 Health News:ATAGO Urine Specific Gravity Refractometers Continue to Catch Drug Test Cheaters 2 Health News:ATAGO Urine Specific Gravity Refractometers Continue to Catch Drug Test Cheaters 3 Health News:Cascade Gasket Utilizes the NOVAtime 4000 SaaS Workforce Management System to Manage Business Processes in Real-Time 2 Health News:Cascade Gasket Utilizes the NOVAtime 4000 SaaS Workforce Management System to Manage Business Processes in Real-Time 3

[0] Semi Truck Accident Victims Center Now Warns Families of A Innocent Victims Seriously Hurt In A Semi Truck Crash To Get A Very Good Legal Team And They Offer To Help [0] Everyone’s Favorite Ogre Coming to Town! CCTA’s Teen Professional Theatre Offers Area Premier of SHREK The Musical [0] San Antonio Community Hospital Earns the Women’s Choice Award for Excellence in Orthopedics [0] ATAGO Urine Specific Gravity Refractometers Continue to Catch Drug Test Cheaters [0] Cascade Gasket Utilizes the NOVAtime 4000 SaaS Workforce Management System to Manage Business Processes in Real-Time

... CHARLOTTE, N.C., Oct. 15 After the success ... Gala, Dienst Custom Homes and the,Make-A-Wish Foundation(R) of ... over 40 wishes to date for Charlotte-area children ... 21, 2007,at a Dienst custom home in the ...

... New Coalition Web Site Launched to Provide Educational Resources to ... of Influenza, ... Importance of Annual Immunization, BETHESDA, Md., Oct. 15 ... http://www.PreventChildhoodInfluenza.org, to support its newly issued report that,calls for ...

... Report finds a doubling of the rate of decline over ... rates from cancer are dropping more quickly across the United ... against a leading killer. , According to a new report, ... 2002 through 2004 -- almost double the 1.1 percent annual ...

... 2007 Post-hoc and other analyses of secondary endpoints ... plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis ... in patients with mild to moderate ulcerative colitis. These ... open-label 12-14 month extension study, are being presented this ...

... 15 Facet Solutions, Inc. announced,today that it ... cohort of,patients to receive its Anatomic Facet Replacement ... one year include a significant,decline in leg and ... complications. Additionally, the first patient in the,AFRS(TM) study ...

... Patients with obstructive sleep apnea (OSA) who also suffer ... positive airway pressure (CPAP) relieves them of symptoms of ... 15 issue of the Journal of Clinical Sleep Medicine ... Center at Universitys Community Hospital in Tampa, Fla., surveyed ...

Dienst Custom Homes Grants Over 40 'Wishes' in Three Years Childhood Influenza Immunization Coalition Issues New Report to Help Improve Low Childhood Influenza Immunization Rates U.S. Cancer Death Rate Continues to Fall New Analyses of long-term LIALDA (mesalamine) data presented at ACG Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up JCSM: CPAP therapy improves symptoms of depression in OSA patients

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

Medicine Products:

Allergen, Tree, Maple Red Tree Allergen, Tree, Elm Tree Allergen, Tree, Birch Tree Allergen, Tree, Alder Tree